Mackenzie Financial’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.8M Buy
+1,297,476
New +$4.41M 0.01% 750
2026
Q1
Sell
-25,298
Closed -$60.3K 1485
2025
Q4
$60.3K Sell
25,298
-866
-3% -$2.37K ﹤0.01% 1614
2025
Q3
$80.1K Buy
+26,164
New +$74.7K ﹤0.01% 1640
2025
Q1
Sell
-78,193
Closed -$246K 1703
2024
Q4
$246K Buy
78,193
+53,076
+211% +$190K ﹤0.01% 1466
2024
Q3
$70.8K Buy
+25,117
New +$57.5K ﹤0.01% 1515
2023
Q2
Sell
-24,649
Closed -$20.8K 1530
2023
Q1
$20.8K Hold
24,649
﹤0.01% 1483
2022
Q4
$22.9K Hold
24,649
﹤0.01% 1394
2022
Q3
$42K Sell
24,649
-1,409
-5% -$3.69K ﹤0.01% 1366
2022
Q2
$56K Buy
+26,058
New +$69.3K ﹤0.01% 1385

Other funds holding CLOV

Mackenzie Financial's CLOV Position: Q2 2026 in Review

Mackenzie Financial opened a new position in Clover Health Investments (CLOV) in Q2 2026: 1,297,476 shares worth $6.8M. The stake represents 0.01% of the portfolio and ranks #750 among its holdings. This is a return to the name: Mackenzie Financial previously reported a position in CLOV as recently as Q4 2025.

Mackenzie Financial first reported a position in CLOV in Q2 2022 and has held it in 9 quarters since. 226 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Mackenzie Financial held 1,297,476 shares of Clover Health Investments worth $6.8M as of Q2 2026.
  • Clover Health Investments was a new Mackenzie Financial position in Q2 2026.
  • Clover Health Investments made up 0.01% of Mackenzie Financial's portfolio in Q2 2026, its #750 holding.
  • Mackenzie Financial first reported a position in Clover Health Investments in Q2 2022 and has held it in 9 quarters since.
  • 226 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.